Jadhav And Sharma Health Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -20.56%
- Profit Growth -92.63%
- Ebitda -79.05%
- Net Worth 2.46%
- Total Assets -15.89%
About Jadhav And Sharma Health Science
Jadhav And Sharma Health Science Private Limited (JASHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 2018 (Six years and seven months 20 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Bal Govind and Bhawana Pachauri serve as directors at the Company.
Company Details
-
Location
Raigarh, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85310MH2018PTC310878
-
Company No.
310878
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jun 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jadhav And Sharma Health Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bal Govind
|
Director | 17-Jun-2018 | Current |
|
Bhawana Pachauri
|
Director | 08-Feb-2024 | Current |
Financial Performance of Jadhav And Sharma Health Science.
Jadhav And Sharma Health Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.56% decrease. The company also saw a substantial fall in profitability, with a 92.63% decrease in profit. The company's net worth moved up by a moderate rise of 2.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jadhav And Sharma Health Science?
Unlock access to Jadhav And Sharma Health Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jadhav And Sharma Health Science?
Unlock and access historical data on people associated with Jadhav And Sharma Health Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jadhav And Sharma Health Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jadhav And Sharma Health Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
